erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
.
"we realized early that this therapy had worked," corinna said of the sweat tests that doctors conducted after her twins, linus and maarten, were born.
.
.updated: may 18, 2018, 10.36 am ist 
   
.